ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.680,20
-0,25%
S&P 500
5.307,01
-0,27%
Dow Jones
39.671,04
-0,51%
Euro vs US Dollar
1,08249
0,00%
Bitcoin
69.500,01
0,57%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. ETFs
  4. USA
  5. AMEX
  6. Invesco Global Clean Energy ETF (PBD)

  7. Invesco Global Clean Energy ETF (PBD) News

PBD

Invesco Global Clean Ene... (PBD)

Invesco Global Clean Energy ETF
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:PBD
DatumZeitQuelleÜberschriftSymbolFirma
29/11/201807h00GlobeNewswireProbiodrug AG Reports Third Quarter 2018 Business UpdateAMEX:PBDInvesco Global Clean Energy ETF
22/11/201807h00GlobeNewswireProbiodrug AG to Publish its Third Quarter 2018 Business Update on November 29, 2018AMEX:PBDInvesco Global Clean Energy ETF
16/10/201807h00GlobeNewswireProbiodrug publishes SAPHIR data in peer reviewed journalAMEX:PBDInvesco Global Clean Energy ETF
15/10/201807h00GlobeNewswireProbiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation ActAMEX:PBDInvesco Global Clean Energy ETF
05/10/201807h00GlobeNewswireProbiodrug Reports Management ChangesAMEX:PBDInvesco Global Clean Energy ETF
04/09/201807h00GlobeNewswireProbiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and StrategyAMEX:PBDInvesco Global Clean Energy ETF
30/08/201807h00GlobeNewswireProbiodrug Reports Financial Results for H1 2018 and Corporate UpdateAMEX:PBDInvesco Global Clean Energy ETF
23/08/201807h00GlobeNewswireProbiodrug AG to Publish First Half 2018 Results on August 30, 2018AMEX:PBDInvesco Global Clean Energy ETF
22/06/201815h00GlobeNewswireOrdinary General Meeting of Shareholders of Probiodrug AGAMEX:PBDInvesco Global Clean Energy ETF
15/05/201807h00GlobeNewswireProbiodrug AG reports First Quarter 2018 Business UpdateAMEX:PBDInvesco Global Clean Energy ETF
09/05/201815h04GlobeNewswireProbiodrug AG to hold its Ordinary General Meeting of Shareholders on 21 June 2018AMEX:PBDInvesco Global Clean Energy ETF
08/05/201809h00GlobeNewswireProbiodrug positioning its pGlu-Abeta Antibody in the field of Abeta antibodiesAMEX:PBDInvesco Global Clean Energy ETF
08/05/201807h00GlobeNewswireProbiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018AMEX:PBDInvesco Global Clean Energy ETF
23/04/201820h45GlobeNewswireProbiodrug Appoints Dr. Ulrich Dauer as Chief Executive OfficerAMEX:PBDInvesco Global Clean Energy ETF
03/04/201807h00GlobeNewswireProbiodrug reports full year 2017 financial resultsAMEX:PBDInvesco Global Clean Energy ETF
27/03/201807h00GlobeNewswireProbiodrug AG to Publish its Full Year 2017 Results on 3 April 2018AMEX:PBDInvesco Global Clean Energy ETF
16/03/201807h00GlobeNewswireProbiodrug to present at 255th ACS National Meeting & ExpositionAMEX:PBDInvesco Global Clean Energy ETF
05/12/201707h00GlobeNewswireProbiodrug AG: Probiodrug and Crossbeta Biosciences extend their strategic partnership in the field of Alzheimer's disease bi...AMEX:PBDInvesco Global Clean Energy ETF
30/11/201708h13GlobeNewswireCORRECTION: Probiodrug AG: Probiodrug reports Third Quarter 2017 Business UpdateAMEX:PBDInvesco Global Clean Energy ETF
30/11/201707h00GlobeNewswireProbiodrug AG: Probiodrug reports Third Quarter 2017 Business UpdateAMEX:PBDInvesco Global Clean Energy ETF
23/11/201707h00GlobeNewswireProbiodrug : Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017AMEX:PBDInvesco Global Clean Energy ETF
26/10/201707h00GlobeNewswireProbiodrug to Present Data from its Phase 2a SAPHIR Study at International Alzheimer's Disease ConferenceAMEX:PBDInvesco Global Clean Energy ETF
16/10/201707h00GlobeNewswireProbiodrug initiates Phase 2b core program of PQ912 and details further strategyAMEX:PBDInvesco Global Clean Energy ETF
31/08/201707h00GlobeNewswireProbiodrug reports financial results for H1 2017 and corporate updateAMEX:PBDInvesco Global Clean Energy ETF
29/08/201707h00GlobeNewswireUnique binding mode of PBD-C06 to pGlu-Abeta peptides identifiedAMEX:PBDInvesco Global Clean Energy ETF
24/08/201707h00GlobeNewswireProbiodrug AG to Publish First Half 2017 Results on 31 August 2017AMEX:PBDInvesco Global Clean Energy ETF
14/06/201716h40GlobeNewswireOrdinary General Meeting of Shareholders of Probiodrug AGAMEX:PBDInvesco Global Clean Energy ETF
14/06/201716h25GlobeNewswireOrdinary General Meeting of Shareholders of Probiodrug AGAMEX:PBDInvesco Global Clean Energy ETF
11/06/201721h07GlobeNewswireProbiodrug announces encouraging results of the Phase 2a SAPHIR StudyAMEX:PBDInvesco Global Clean Energy ETF
16/05/201707h00GlobeNewswireProbiodrug AG Announces Acceptance of PQ912 Pharmacology Paper by Peer Reviewed JournalAMEX:PBDInvesco Global Clean Energy ETF
 Showing the most relevant articles for your search:AMEX:PBD

Kürzlich von Ihnen besucht

TG
ALV
Allianz
DBI
TDXP
Tec DAX
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
XOM
Exxon Mobil
NYSE
NKE
Nike
TG
BAS
BASF
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
TG
MBG
MercedesBenz
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten